Hexosylceramides and glycerophosphatidylcholine GPC(36:1) increase in Multi-Organ Dysfunction Syndrome patients with Pediatric Intensive Care Unit Admission over 8-day hospitalization

Mara L. Leimanis-Laurens, Emily Wolfrum, Karen Ferguson, Jocelyn R. Grunwell, Dominic Sanfilippo, Jeremy W Prokop, Todd A. Lydic, Surender Rajasekaran
doi: https://doi.org/10.1101/2021.02.11.21251596
Back to top
Posted February 18, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Hexosylceramides and glycerophosphatidylcholine GPC(36:1) increase in Multi-Organ Dysfunction Syndrome patients with Pediatric Intensive Care Unit Admission over 8-day hospitalization
Mara L. Leimanis-Laurens, Emily Wolfrum, Karen Ferguson, Jocelyn R. Grunwell, Dominic Sanfilippo, Jeremy W Prokop, Todd A. Lydic, Surender Rajasekaran
medRxiv 2021.02.11.21251596; doi: https://doi.org/10.1101/2021.02.11.21251596
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area